Aziyo Biologics Inc expected to post a loss of 69 cents a share - Earnings Preview

Elutia

20/03/2023 20:29

* Aziyo Biologics Inc  AZYO.OQ   AZYO.O  is expected to show
a
rise in quarterly revenue when it reports  results on March 22. 
    * The Silver Spring Maryland-based  company is expected to
report 
a 15.6% increase in revenue to $12.55 million from $10.86
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Aziyo Biologics Inc
is
for a loss of 69 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $13​, above​ its last closing price of $3.90. ​​​

This summary was machine generated March 20 at 20:28 GMT.  All
figures in US dollars  unless otherwise stated